Minerva Neurosciences
NERV
17 hedge funds and large institutions have $46.7M invested in Minerva Neurosciences in 2015 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 3 closing their positions.
156% more capital inflows, than outflows
Capital inflows: $929K | Capital outflows: $363K
133% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 3
0.4% more ownership
Funds ownership: 35.58% → 35.98% (+0.4%)
6% less funds holding
Funds holding: 18 → 17 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$691K |
| 2 |
Bridgeway Capital Management
Houston,
Texas
|
+$104K |
| 3 |
Highland Capital Management (Texas)
Dallas,
Texas
|
+$81.2K |
| 4 |
Tower Research Capital (TRC)
New York
|
+$18.4K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$14.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$182K |
| 2 |
Spark Investment Management
New York
|
-$177K |
| 3 |
BlackRock Fund Advisors
San Francisco,
California
|
-$3.12K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1K |
| 5 |
Morgan Stanley
New York
|
-$230 |
NERV Hedge Fund Activity: Q3 2015 in Review
17 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q3 2015, worth a combined $46.7M — down 8.5% from $51M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of NERV and 2 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 7 added.
The largest buyer was Federated Hermes, adding an estimated $691K. The largest seller was Jacobs Levy Equity Management, exiting entirely with an estimated $182K sold.
- 17 institutional investors held Minerva Neurosciences (NERV) as of Q3 2015, down from 18 in Q2 2015.
- Funds reported $46.7M of Minerva Neurosciences stock for Q3 2015, down 8.5% quarter-over-quarter.
- 2 funds opened new Minerva Neurosciences positions in Q3 2015 and 3 closed out, a net change of -1 holder.
- The largest Minerva Neurosciences buyer in Q3 2015 was Federated Hermes, an estimated $691K added.
- The largest Minerva Neurosciences seller in Q3 2015 was Jacobs Levy Equity Management, an estimated $182K sold.
Based on aggregated 13F filings for Q3 2015.